S&P 5007,561.67-0.40%DOW52,347.55+0.10%NASDAQ25,136.27-0.91%BTC$68,258.00-3.68%ETH$1,927.42-4.09%GOLD$3,887.60+0.06%OIL$88.92+0.20%

NASDAQ · LXRX

Lexicon Pharmaceuticals, Inc.

Healthcare · Biotechnology

$1.79

Down-$0.03 (-1.65%)

Updated Nov 14, 2026, 2:10 PM

SID Score

5.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 481.5M
P/E ratio: -3.99
Dividend yield: 0.00%
52-week range: $1.37 – $2.68
Volume: 1.89M
Avg. volume: 2.31M

Price performance · LXRX

LXRX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 13, 2026

Last close: $1.79
Period change: +17.76%
Period low: $1.42
Period high: $1.87

Daily close

View OHLC price history

LXRX OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Nov 13, 2026	$1.83	$1.83	$1.72	$1.79	1.89M
Nov 12, 2026	$1.87	$1.89	$1.78	$1.82	1.69M
Nov 11, 2026	$1.87	$1.92	$1.85	$1.87	3.09M
Nov 10, 2026	$1.80	$1.9695	$1.80	$1.86	3.41M
Nov 9, 2026	$1.88	$1.9178	$1.79	$1.82	2.56M
Nov 6, 2026	$1.66	$1.84	$1.61	$1.78	3.6M
Nov 5, 2026	$1.57	$1.6399	$1.51	$1.61	3.8M
Nov 4, 2026	$1.50	$1.54	$1.46	$1.48	1.95M
Nov 3, 2026	$1.44	$1.515	$1.44	$1.46	1.04M
Nov 2, 2026	$1.44	$1.45	$1.40	$1.44	2.02M
Oct 30, 2026	$1.47	$1.4961	$1.375	$1.42	2.44M
Oct 29, 2026	$1.50	$1.52	$1.43	$1.48	1.77M
Oct 28, 2026	$1.47	$1.49	$1.43	$1.485	1.62M
Oct 27, 2026	$1.47	$1.49	$1.435	$1.48	1.86M
Oct 26, 2026	$1.40	$1.48	$1.40	$1.45	2.21M
Oct 23, 2026	$1.50	$1.50	$1.365	$1.42	2.68M
Oct 22, 2026	$1.56	$1.59	$1.48	$1.49	1.32M
Oct 21, 2026	$1.59	$1.6171	$1.545	$1.56	1.4M
Oct 20, 2026	$1.56	$1.63	$1.545	$1.58	1.41M
Oct 19, 2026	$1.55	$1.5799	$1.5102	$1.55	1.72M
Oct 16, 2026	$1.68	$1.68	$1.52	$1.52	2.01M

Latest LXRX news

The latest Smart Investors Daily articles mentioning LXRX.

Featured By

Inc.

Nasdaq

Filter news

Filters are reflected in the page URL for sharing and back-button support.

LXRX news

4 matching articles.

Yahoo · Nov 11, 2026

Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London

THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London. The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/. About Lexic

Benzinga · Nov 9, 2026

Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.4

Citigroup analyst Yigal Nochomovitz maintains Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and raises the price target from $3.1 to $3.4.

Yahoo · Nov 9, 2026

New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy

-- In a randomized crossover study, sotagliflozin significantly reduced ex vivo thrombus formation from baseline under both arterial and venous flow conditions -- -- Study in living human heart tissue indicate sotagliflozin acutely and directly reduces myocardial work in hypertrophic cardiomyopathy (HCM) -- -- Findings add mechanistic insight into sotagliflozin's dual SGLT1/SGLT2 inhibition ahead of SONATA-HCM topline results in Q1 2027 -- THE WOODLANDS, Texas, Nov. 09, 2026 (GLOBE NEWSWIRE) --

Benzinga · Nov 9, 2026

Lexicon Pharma Presents New Data Highlighting Cardiovascular Effects Of Dual SGLT1/2 Inhibitor, Sotagliflozin, At AHA Scientific Sessions 2026

-- In a randomized crossover study, sotagliflozin significantly reduced ex vivo thrombus formation from baseline under both arterial and venous flow conditions ---- Study in living human heart tissue indicate